03Agentic Operations & Platform Strategy
Operating leverage,
not AI demos.
For organizations rebuilding clinical and administrative workflows with AI agents, and deciding whether to buy, build, or run a hybrid. This is the cornerstone where our point of view is sharpest.
The work
Not a chatbot bolted onto an EHR.
Agentic AI in healthcare is a redesign of how clinical events flow between systems, how administrative work gets assigned, and how patients experience the practice. Done well, it removes the work nobody should be doing and lets clinicians and operators focus on the work only they can do. Done poorly, it adds latency and risk.
We build agentic infrastructure for medical practices as our day job at Cara. We know where agents reliably outperform humans, where they don’t, and where the integration cost eats the productivity gain. We bring that hands-on perspective to clients trying to make build-versus-buy decisions, evaluate vendors, or redesign their own clinical and administrative operations.
Where we work
Four shapes of engagement.
AI strategy and roadmap
For provider platforms, payers, health systems, and digital health companies. A roadmap with dollar costs, FTE savings, and a sequence the operating team can defend in a board meeting.
Agentic workflow design
Patient intake, scheduling, eligibility, prior auth, clinical documentation, care coordination, billing exceptions. The workflows where agents reliably outperform humans, and the ones where they don't.
Integration architecture
EHR and CRM integration, clinical event normalization across acquired EHRs in PE-backed rollups. The plumbing that decides whether the AI strategy is real or theater.
Build, buy, or partner
Independent assessment of internal platforms, vendor stacks, and reference architectures. We deploy the Cara platform when it fits the operating thesis, including patient acquisition, intake, scheduling, payments, portal, and workflow automation. We say so when it doesn't.
What changes
You stop confusing AI demos with operating leverage. You can articulate, in dollars and FTEs, what a given agent removes from the workflow and what it costs to keep it running. Your technology spend reflects a strategy, not a series of vendor decisions made in different quarters.
Call us if
Any of these are true.
- ◆You are seeing AI vendor pitches every week and have no internal framework for evaluating them.
- ◆A PE platform thesis depends on operating leverage from automation that isn't yet quantified.
- ◆A health system, payer, or pharma innovation team is being asked to deliver an AI roadmap and needs an operator's perspective rather than a consultant's.
- ◆You want to know honestly whether to build your own agentic stack, partner, or adopt the Cara platform.
Operator proof
Done before, at scale.
Selected outcomes from prior operating roles. Client names withheld.
30 states
Virtual care product launched, 90% of US population reached
40%
In-person visit conversion to virtual across a $1.2B care delivery business
Delivery
Delivered through Cara Embedded, on the Cara platform.
Forward deployed engineering and product management on top of the same agentic infrastructure we build for our own customers. Platform optional, but most engagements use it because it removes six months of plumbing.